|
|
||||||||
Published online before print September 12, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
@,
,
,
,
*Center for Pulmonary and Infectious Disease Control, Departments of
Microbiology and Immunology and
Medicine, University of Texas Health Center, Tyler; and
Department of Internal Medicine, University of North Texas Health Sciences Center, Fort Worth
@ To whom correspondence should be addressed. E-mail: amir.shams{at}uthct.edu.
| Abstract |
|---|
Mycobacterium tuberculosis antigens that are recognized by human CD8+ T cells are potentially important vaccine target molecules. We used a motif-based strategy to screen selected proteins of M. tuberculosis for peptides predicted to bind to human leukocyte antigen (HLA)-A*0201. We identified two 10 amino acid peptides that elicited cytolytic T lymphocyte activity and interferon-
production by CD8+ T cells from HLA-A*0201+ healthy tuberculin reactors. These peptides were derived from the 38-kDa antigen and the 28-kDa hemolysin, the latter being a novel target for CD8+ T cells. We speculate that hemolysins may alter the phagosomal membrane surrounding intracellular M. tuberculosis, allowing themselves and other antigens to gain access to the major histocompatibility complex class I processing pathway.
Key Words: cytolytic T lymphocyte HLA-A*0201 bacillus Calmette-Guerin
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |